Johnson Investment Counsel’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-9,737
Closed -$675K 618
2017
Q1
$675K Hold
9,737
0.02% 316
2016
Q4
$649K Sell
9,737
-980
-9% -$63.8K 0.02% 308
2016
Q3
$710K Sell
10,717
-41,521
-79% -$2.84M 0.02% 275
2016
Q2
$3.78M Sell
52,238
-350
-0.7% -$24.1K 0.12% 124
2016
Q1
$3.4M Sell
52,588
-5,080
-9% -$337K 0.12% 130
2015
Q4
$4.13M Sell
57,668
-1,253
-2% -$92.7K 0.14% 114
2015
Q3
$4.52M Sell
58,921
-3,950
-6% -$319K 0.17% 103
2015
Q2
$4.66M Sell
62,871
-597
-0.9% -$43K 0.16% 105
2015
Q1
$4.6M Sell
63,468
-1,490
-2% -$104K 0.15% 105
2014
Q4
$4.29M Sell
64,958
-13,432
-17% -$820K 0.14% 109
2014
Q3
$4.3M Buy
78,390
+210
+0.3% +$11.9K 0.14% 103
2014
Q2
$4.55M Sell
78,180
-435
-0.6% -$25.6K 0.16% 95
2014
Q1
$4.87M Sell
78,615
-4,810
-6% -$280K 0.18% 86
2013
Q4
$4.45M Sell
83,425
-1,765
-2% -$94.7K 0.16% 97
2013
Q3
$4.28M Buy
85,190
+6,720
+9% +$328K 0.17% 94
2013
Q2
$3.59M Buy
+78,470
New +$3.51M 0.15% 98

Other funds holding MD

Johnson Investment Counsel's MD Position: Q2 2017 in Review

Johnson Investment Counsel sold out of Pediatrix Medical (MD) in Q2 2017, closing a stake of 9,737 shares — an estimated $675K sold.

Johnson Investment Counsel first reported a position in MD in Q2 2013 and held it in 16 quarters. The position peaked at $4.87M in Q1 2014. 332 funds tracked by Wall St. Rank hold MD as of Q2 2017.

  • Johnson Investment Counsel reported no remaining Pediatrix Medical position as of Q2 2017 after selling out during the quarter.
  • Johnson Investment Counsel sold 9,737 Pediatrix Medical shares in Q2 2017, an estimated $675K.
  • Johnson Investment Counsel first reported a position in Pediatrix Medical in Q2 2013 and held it in 16 quarters.
  • Johnson Investment Counsel's Pediatrix Medical position peaked at $4.87M in Q1 2014.
  • 332 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2017.

Based on Johnson Investment Counsel's 13F filing for Q2 2017, filed 14 Aug 2017.